...
首页> 外文期刊>Nuclear Medicine and Biology >Preparation of cyclotron-produced Re-186 and comparison with reactor-produced Re-186 and generator-produced Re-188 for the labeling of bombesin
【24h】

Preparation of cyclotron-produced Re-186 and comparison with reactor-produced Re-186 and generator-produced Re-188 for the labeling of bombesin

机译:制备回旋加速器生产的Re-186,并与反应堆生产的Re-186和发生器生产的Re-188进行比较,以标记蛙皮素

获取原文
获取原文并翻译 | 示例
           

摘要

The radioisotopes Re-186 and Re-188 have been extensively investigated for various forms of radiotherapy due to their useful and high-abundance particle emissions, low-abundance and imageable gamma-rays, and chemical resemblance to technetium. In addition. Re-188 is available in no-carrier-added (NCA) form from long lived W-188 generators, whereas Re-186 can be produced in large quantities from reactors, although not in NCA form. However NCA Re-186 can be produced on a cyclotron by a (p,n) reaction on W-186. The purpose of this Study was to compare labeling of the peptide bombesin with these three forms of rhenium radioisotopes.
机译:由于放射性同位素Re-186和Re-188有用且高丰度的粒子发射,低丰度和可成像的伽马射线以及与tech的化学相似性,因此已广泛研究了各种形式的放射疗法。此外。 Re-188可以通过长期使用的W-188发电机以无载流子(NCA)的形式获得,而Re-186可以从反应堆中大量生产,尽管不是NCA形式。但是,NCA Re-186可以在回旋加速器上通过W-186上的(p,n)反应生成。这项研究的目的是比较肽蛙皮素与这三种形式的rh放射性同位素的标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号